LeonaBio, Inc. Proceeds from Collection of Loans Receivable
LeonaBio, Inc. (LONA) reported Proceeds from Collection of Loans Receivable of $36.00 thousand for the 12-month period ending 2020-12-31, per its 10-K filed 2022-03-28.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromCollectionOfLoansReceivable · last filed 2022-03-28
- LeonaBio, Inc. proceeds from collection of loans receivable for the quarter ending 2020-12-31 was $0.00, a 100.00% decline year-over-year.
- LeonaBio, Inc. proceeds from collection of loans receivable for the quarter ending 2020-09-30 was $33.00K.
- LeonaBio, Inc. proceeds from collection of loans receivable for the quarter ending 2020-06-30 was $2.00K.
- LeonaBio, Inc. proceeds from collection of loans receivable for the quarter ending 2020-03-31 was $1.00K.
- LeonaBio, Inc. proceeds from collection of loans receivable for fiscal 2020 was $36.00K, a 500.00% increase from fiscal 2019.
- LeonaBio, Inc. proceeds from collection of loans receivable for fiscal 2019 was $6.00K.
| Period end | Proceeds from Collection of Loans Receivable 3 month | Proceeds from Collection of Loans Receivable 6 month | Proceeds from Collection of Loans Receivable 9 month | Proceeds from Collection of Loans Receivable 12 month |
|---|---|---|---|---|
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $33.00K derived: sum of 2 quarters · filed 2022-03-28 | $35.00K derived: sum of 3 quarters · filed 2022-03-28 | $36.00K 10-K · filed 2022-03-28 |
| 2020-09-30 | $33.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $35.00K derived: sum of 2 quarters · filed 2021-11-10 | $36.00K 10-Q · filed 2021-11-10 | $37.00K derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $2.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | $3.00K 10-Q · filed 2021-08-16 | $4.00K derived: sum of 3 quarters · filed 2021-08-16 | |
| 2020-03-31 | $1.00K 10-Q · filed 2021-05-13 | $2.00K derived: sum of 2 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $6.00K 10-K · filed 2021-03-25 | ||
| 2019-09-30 | $5.00K 10-Q · filed 2020-11-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |